Tumor markers and biochemical parameters in colon cancer patients before and after chemotherapy

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 11, 2011, Pages 3147-3150

  Gür, Tuǧba ^a   Demir, Halit ^a   Kotan, M Çetin ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

ALT; AST; Carbonic anhydrase; Catalase; Colon cancer

Indexed keywords

EID: 84863334841     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Aebi H (1984). Catalase in vitro. Methods Enzymol, 105, 121-6.
2. Arnold CN, Goel A, Blum HE, Boland CR (2005). Molecular pathogenesis of colorectal cancer. Cancer, 104, 2035-47.
3. Barton JB, Langdale LA, Cummins JS, et al (2002). The utility of routine preoperative tomography scanning in the management of veterans with colon cancer. Am J Surg, 183, 499-503.
4. Colomer R, Ruibal A, Genollà J, Salvador L (1989). Circulating CA-15.3 antigen levels in non mammary malignancies. Br J Cancer, 59, 283-6.
5. Demir H, Akkus ZA, Cebi A, Tahir Cakir T, Izmirli, M (2010). Catalase, carbonic Anhydrase and other biochemical parameters in esophageal cancers in Turkey. Asian Pac J Cancer Prev, 11, 1029-32.
6. Dymicka-Piekarska V, Matowicka-Karna J, et al (2007). Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer. Thromb Res, 120, 585-90.
7. Engwegen JY, Helgason HH, Cats A, Harris N, Bonfrer JM (2006). Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. World J Gastroenterol, 12, 1536-44.
8. Gabay C, Kushner I (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 340, 448-54.
9. Gan WQ, Man SF, Senthilselvan A, Sin DD (2004). Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax, 59, 574-80.
10. Gullino PM, Grantham FH, Smith SH, et al (1965). Modifications of the acid-base status of the internal milieu of tumors. J Natl Cancer Inst, 34, 857-69.
11. Halliwell B (2007). Oxidative stress and cancer: have we moved forward? Biochem J, 401, 1-11.
12. Hwang TS, Choi HK, Han HS (2007). Differential expression of manganese superoxide dismutase, copper/zinc superoxide dismutase, and catalase in gastric adenocarcinoma and normal gastric mucosa. EJSO, 33, 474-9.
13. Kemeny N, Braun DW Jr (1983). Prognostic factors in advanced colorectal carcinoma. Importance of lactic dehydrogenase level, performance status, and white blood cell count. Am J Med, 74, 786-94.
14. Kim H, Kim S, Jee SH (2010). The Independent effects of cigarette smoking, alcohol consumption, and serum aspartate aminotransferase on the alanine aminotransferase ratio in Korean men for the risk for esophageal cancer. Yonsei Med J, 5, 310-7.
15. Koprowski H, Herlyn M, Steplewski Z, Sears HF (1981). Specific antigen in serum of patients with colon carcinoma. Science, 212, 53-5.
16. Li{dotless}n JT, Wang WS, Yen CC, Li{dotless}u JH, Yang MH (2005). Outcome of colorectal carcinoma in patients under 40 years of age. J Gastroenterol Hepatol, 20, 900-5.
17. Liotta LA (1986) Tumor invasion and metastasis role of extracellular matrix. Rhodes memorial award lecture. Cancer Res, 46, 1-7.
18. McMillan DC, Talwar D, Sattar N, Underwood M, O'Reilly DS (2002). The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. Clin Nutr, 21, 161-4.
19. Nozoe T, Matsumata T, Kitamura M, Sugimachi K (1998). Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg, 176, 335-8. [PMID: 9817250]
20. Ojima T, Iwahashi, M, Nakamura, M, Matsuda, K, Nakamori, M (2006). Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice. Int J Cancer, 120, 585-93.
21. Otterness IG (1994). The value of C-reactive protein measurement in rheumatoid arthritis. Semin Arthritis Rheum, 24, 91-104.
22. Pepys MB (2005). CRP or not CRP? That is the question. Arterioscler Thromb Vasc Biol, 25, 1091-4.
23. Thompson JA, Grunert F, Zimmermann W (1991). Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal, 5, 344-66.
24. Parkin DM, Bray F, Pisani P (2005). Global cancer statistics. CA Cancer J Clin, 55, 74-108.
25. Rickli EE, Ghazanfar SAS, Gibbons BH, et al (1964). Carbonic anhydrase from human erytrocytes. J Biol Chem, 239, 1065-78.
26. Skrzydlewska E, Kozuszko B, Sulkowska M, Bogdan Z, Kozlowski M (2003). Antioxidant potential in esophageal, stomach and colorectal cancers. Hepatogastroenterology, 50, 126-31.
27. Sly WS, Hu PY (1995). Human carbonic anhydrases and carbonic anhydrase deficiencies. Ann Rev Biochem, 64, 375-401
28. Symeonidisa A, Kouraklis A, Dimitris S, Evangelia A, Nikolaos A (2004). Increased serum CA-15.3 levels in patients with megaloblastic anemia due to Vitamin B12 deficiency. Oncology, 67, 359-67.
29. Turkiewicz D, Miller B, Schache D, Cohen J, Theile D (2001). Young patients with colorectal cancer: how do they fare? ANZ J Surg, 71, 707-10.
30. Tsilidis KK, Branchini C, Guallar, E, Helzlsouer KJ, Thomas P (2008). Platz. C-reactive protein and colorectal cancer risk: A systematic review of prospective studies. Int J Cancer, 123, 1133-40.
31. Zaloudik J, Lauerova L, Janakova L, Talac R, Simickova M (1999). Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver. Hepatogastroenterology, 46, 220-7.
32. Zavada J, Zavadova Z, Pastorekova S, et al (1993). Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer, 54, 268 -74.